NAFLD care pathway for veterans
Part of Digestive system clinical trials.
This trial tests a new care pathway for non-alcoholic fatty liver disease (NAFLD) in veterans. It aims to improve how patients are diagnosed and treated through their primary care team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at a VA Medical Center.
- Your primary care team is part of the Patient Aligned Care Teams (PACT) program.
- Your team is located at the main hospital (not a clinic).
- Your team has at least 100 visits in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests electronic tools to help doctors identify and care for patients with steatotic liver disease (fatty liver). If you have risk factors like diabetes or elevated liver enzymes, this trial may help improve your care.
This study uses multiple types of health data (“multi-omics”) to help choose a personalized treatment plan for people with obesity-related fatty liver disease. It may help match treatment to your biology to improve outcomes.
This trial studies whether a lifestyle program can improve fatty liver disease in people who also have metabolic syndrome (a cluster of health problems like high blood sugar and cholesterol). It may help by improving liver health through diet, activity, and other lifestyle changes.
This study tests a new way to help people with fatty liver disease (MASLD or MASH) become more physically active. You'll use a computer to participate, and the goal is to see if this approach is acceptable and helpful for people like you.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study follows adults with nonalcohol-related fatty liver disease (NAFLD) to better understand the condition and what factors affect it. It may help researchers learn which patients are most at risk and how care can be improved in the future.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.